From Medscape Oncology

Coverage from the

Society of Gynecological Oncology (SGO) Annual Meeting 2020

March 28 - 31, 2020; Toronto, Canada

March 28 - 31, 2020 Toronto, Canada

SGO 2020 Water-Only Fasting May Reduce Chemo Modifications Patients with gynecologic malignancies who consumed only water for 24 hours before and after each chemo cycle had fewer dose delays and reductions compared with patients who didn't fast, a small study showed.
Medscape Medical News, April 8, 2020
SGO 2020 Advanced Ovarian Cancer: Survival & NAC Use Continue to Increase Survival of patients with advanced ovarian cancer continues to increase, despite concerns that increased use of neoadjuvant chemotherapy (NAC) could have a negative impact on outcomes.
Medscape Medical News, April 2, 2020

Conference News

SGO 2020 Water-Only Fasting May Reduce Chemo Modifications
Medscape Medical News, April 8, 2020
SGO 2020 Weight Loss Intervention Fails in Endometrial Cancer Survivors
Medscape Medical News, April 8, 2020
SGO 2020 Promising Efficacy With Adavosertib in Uterine Serous Carcinoma
Medscape Medical News, April 3, 2020

SGO 2020 Financial Toxicity Is Common With Gynecologic Cancers
Medscape Medical News, April 2, 2020
SGO 2020 Younger Gynecologic Cancer Patients at Risk for Early Bone Loss
Medscape Medical News, April 2, 2020
SGO 2020 Advanced Ovarian Cancer: Survival & NAC Use Continue to Increase
Medscape Medical News, April 2, 2020

Popular News from SGO 2019

Novel Handheld Device Detects High-Risk HPV in 2 Hours Several innovative strategies are successfully detecting high-risk human papillomavirus (HPV) types with technologies that do not require a resource-rich setting to perform well.
Medscape Medical News, Mar 19, 2019
Two Surgeries at Once: Endometrial Cancer & Stress Incontinence Women who require surgery for endometrial cancer enjoy a better quality of life if concomitant stress urinary incontinence is surgically repaired at the same time.
Medscape Medical News, Mar 26, 2019
Surgery to Reduce Ovarian Cancer Risk — One Step or Two? Results from TUBA and WISP show high-risk women have few remaining cancer worries or decision regrets after undergoing prophylactic surgery to reduce ovarian cancer risk.
Medscape Medical News, Mar 25, 2019

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

SGO 2019